...
首页> 外文期刊>Journal of Thoracic Disease >Myelomatous pleural effusion as an initial sign of multiple myeloma—a case report and review of literature
【24h】

Myelomatous pleural effusion as an initial sign of multiple myeloma—a case report and review of literature

机译:骨髓瘤性胸腔积液为多发性骨髓瘤的初步征象—病例报告和文献复习

获取原文

摘要

Objective: Discuss and improve the understanding of the clinical characters and diagnostic methods of myelomatous pleurisy, particularly of the patients with pleural effusion as an initial manifestation. Background: A 53-year-old male, who had been misdiagnosed as tuberculous pleurisy in a local hospital, was diagnosed as multiple myeloma (MM) with pleural infiltration. We reviewed the literature on clinical manifestations, serum and pleural effusion characters, treatment and diagnostic options of this exceptionally rare presentation of MM. Methods: We conducted a search of the published medical literature since 2000 in MEDLINE and PubMed using search criteria [(“pleural effusion” and “MM”) or “myelomatous pleural effusions”]. The search led to 64 case reports, and 16 cases with pleural effusion as an initial manifestation were included in this review. We have also searched for recent advances in diagnosis. Results and conclusions: Myelomatous pleurisy is a rare complication of MM. Its clinical and laboratory findings are non-specific. Definitive diagnosis relies on the histopathology of pleural biopsy or pleural effusion. Thoracoscopic pleural biopsy is reliable, safe and effective. Chemotherapy is the mainstay of treatment for myelomatous pleural effusion. However, the response rate is low with an overall median survival time of 4 months.
机译:目的:讨论并增进对骨髓瘤性胸膜炎的临床特征和诊断方法的理解,尤其是对于以胸腔积液为主要表现的患者。背景:一名53岁的男性在当地医院被误诊为结核性胸膜炎,被诊断为伴有胸膜浸润的多发性骨髓瘤(MM)。我们回顾了有关这种罕见的MM表现的临床表现,血清和胸腔积液特征,治疗和诊断选择的文献。方法:我们使用检索标准[(“胸腔积液”和“ MM”)或“骨髓瘤性胸腔积液”]对2000年以来在MEDLINE和PubMed中发表的医学文献进行了检索。该检索导致64例病例报告,其中16例以胸腔积液为初始表现的病例纳入了该评价。我们还搜索了诊断的最新进展。结果与结论:骨髓瘤性胸膜炎是MM的一种罕见并发症。其临床和实验室检查结果非特异性。明确的诊断取决于胸膜活检或胸腔积液的组织病理学。胸腔镜胸膜活检术可靠,安全,有效。化学疗法是骨髓瘤性胸腔积液的主要治疗手段。但是,反应率很低,总生存期为4个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号